| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.64 | 6e-05 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |